China Resources Pharmaceutical Group Limited (HKG: 3320)

China Resources Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	34,114	32,229	39,705	22,303	25,004	45,437
Market Cap Growth	-15.10%	-18.83%	78.03%	-10.80%	-44.97%	-29.26%
Enterprise Value	132,796	125,637	127,867	104,251	93,118	94,020
Last Close Price	5.43	4.89	5.90	3.20	3.51	6.21
PE Ratio	8.51	7.59	10.03	4.82	6.39	12.36
Forward PE	6.94	6.11	8.75	5.81	6.69	8.75
PS Ratio	0.13	0.12	0.16	0.08	0.11	0.20
PB Ratio	0.66	0.31	0.44	0.19	0.26	0.58
P/TBV Ratio	1.78	1.63	2.09	0.98	1.07	2.47
P/FCF Ratio	2.00	2.25	4.11	1.74	3.22	6.26
P/OCF Ratio	1.85	1.88	3.25	1.41	2.57	4.99
PEG Ratio	0.94	-	-	-	-	0.62
EV/Sales Ratio	0.49	0.47	0.52	0.36	0.39	0.41
EV/EBITDA Ratio	8.12	8.40	9.68	7.11	7.08	8.38
EV/EBIT Ratio	10.33	10.33	11.61	8.63	8.40	10.07
EV/FCF Ratio	7.80	8.75	13.24	8.14	11.99	12.95
Debt / Equity Ratio	0.78	0.67	0.70	0.72	0.69	0.78
Debt / EBITDA Ratio	5.14	4.38	4.59	5.37	4.69	5.08
Debt / FCF Ratio	4.80	4.77	6.60	6.52	8.44	8.38
Asset Turnover	0.97	1.06	1.00	1.03	1.00	1.12
Inventory Turnover	6.09	7.06	6.99	7.42	7.17	7.77
Quick Ratio	1.02	1.00	0.94	0.95	0.92	0.96
Current Ratio	1.37	1.33	1.25	1.25	1.20	1.25
Return on Equity (ROE)	8.94%	8.96%	8.09%	7.60%	7.12%	7.84%
Return on Assets (ROA)	2.78%	2.99%	2.80%	2.69%	2.92%	2.85%
Return on Capital (ROIC)	4.32%	4.72%	4.33%	4.13%	4.50%	4.38%
Earnings Yield	11.16%	13.17%	9.97%	20.74%	15.66%	8.09%
FCF Yield	46.83%	44.53%	24.32%	57.39%	31.05%	15.98%
Dividend Yield	3.26%	3.47%	2.71%	5.76%	4.06%	1.98%
Payout Ratio	23.30%	22.83%	23.23%	20.00%	20.96%	24.86%
Buyback Yield / Dilution	-	-	0.01%	0.02%	-
Total Shareholder Return	3.26%	3.47%	2.71%	5.77%	4.08%	1.98%

Source: S&P Capital IQ. Standard template. Financial Sources.